Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?

To: shero who wrote (2789)	12/12/1998 2:56:00 PM
From: shero	Read Replies (1) \| Respond to of 3702

Golfdad 97--I don't think I said, and I certainly didn't mean to imply that you were/are a mgmt basher. Indeed its been your posts and those of a few others that rescued Yahoo!! for its quagmire of pouting children hurling explectives (sp) at each other. If anything I've been the one guilty of bashing (the old) mgmt. Today's a new day. I'm going to give these guys every opportunity to move this technology from the lab to the clinic. And I'm encouraged on that front. Only 7 months from start to finish for phase 1 TNT and only an additional 2 months to start phase 2 TNT. I think the reason we don't see much on LYM one is because of a sort of "quiet period" while a contract gets wrapped up, and I also don't think there is much to say, yet. The protocol for this trial is terrible, how do you find patients who have failed 2 courses of chemo and are still "reassonably" healthy. And because of the protocol in the phase 2 part of this phase 2/3 trial, how do I say this, I think the first 15 patients died with only one or two living long enough to receive a therapeutic dose. Another case of the FDA worrying about something other than terminal cancer killing the patient. But at least the FDA doesn't have to worry about...sorry, I'm digressing. Please keep up your very informative posts. Everyone appreciates the info you supply.